Brad Sherburne

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Genetic alterations in malignant tissues are potential targets for gene–based cancer therapies. Alternatively, aberrant expression of certain specific genes associated with malignant transformation may be envisioned to enhance the expression of chemosensitizing drugs. Epstein–Barr virus (EBV)–related B–cell lymphomas are fatal complications of(More)
  • 1